Eliminating latent tuberculosis

被引:169
作者
Young, Douglas B. [1 ,2 ]
Gideon, Hannah P. [3 ]
Wilkinson, Robert J. [1 ,3 ,4 ]
机构
[1] Natl Inst Med Res, London NW7 1AA, England
[2] Univ London Imperial Coll Sci Technol & Med, Div Investigat Sci, London SW7 2AZ, England
[3] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa
[4] Univ London Imperial Coll Sci Technol & Med, Div Med, London W2 1PG, England
基金
英国惠康基金;
关键词
TUMOR-NECROSIS-FACTOR; HEALTH-CARE WORKERS; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; HYPOXIC RESPONSE; IMMUNE RECONSTITUTION; TUBERCLE-BACILLI; ALPHA-CRYSTALLIN; DORMANCY REGULON; LUNG-TISSUE;
D O I
10.1016/j.tim.2009.02.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tuberculosis is recognized as the world's leading bacterial cause of death. Yet 95% of infection is believed to exist in an asymptomatic 'latent' form that is defined not by the identification of bacteria, but by the host immune response in the form of reactivity to tuberculosis proteins in the tuberculin skin test. It seems likely that clinically defined latent tuberculosis actually represents a spectrum that runs from elimination of live bacilli to subclinical disease: hence, it might be unhelpful to use a single term to describe all these conditions. To support this view, here we focus on recent increased understanding of the heterogeneity in both bacillary physiology and host immune response that potentially illuminates new therapeutic and diagnostic approaches to this condition.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 64 条
[1]   Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover [J].
Almeida, Jorge R. ;
Price, David A. ;
Papagno, Laura ;
Arkoub, Zaina Ait ;
Sauce, Delphine ;
Bornstein, Ethan ;
Asher, Tedi E. ;
Samri, Assia ;
Schnuriger, Aurelie ;
Theodorou, Ioannis ;
Costagliola, Dominique ;
Rouzioux, Christine ;
Agut, Henri ;
Marcelin, Anne-Genevieve ;
Douek, Daniel ;
Autran, Brigitte ;
Appay, Victor .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (10) :2473-2485
[2]   Transmission of Mycobacterium tuberculosis undetected by tuberculin skin testing [J].
Anderson, ST ;
Williams, AJ ;
Brown, JR ;
Newton, SM ;
Simsova, M ;
Nicol, MP ;
Sebo, P ;
Levin, M ;
Wilkinson, R ;
Wilkinson, KA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (09) :1038-1042
[3]  
[Anonymous], 2008, Global tuberculosis control - surveillance, planning, financing
[4]  
[Anonymous], COCHRANE DATABASE SY
[5]   Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis [J].
Aziz, Mohamed Abdel ;
Wright, Abigail ;
Laszlo, Adalbert ;
De Muynck, Aime ;
Portaels, Francois ;
Van Deun, Armand ;
Wells, Charles ;
Nunn, Paul ;
Blanc, Leopold ;
Raviglione, Mario .
LANCET, 2006, 368 (9553) :2142-2154
[6]  
BARNES PF, 1990, J IMMUNOL, V145, P149
[7]   Tuberculosis - Metabolism and respiration in the absence of growth [J].
Boshoff, HIM ;
Barry, CE .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (01) :70-80
[8]   Experimental Mycobacterium tuberculosis infection of cynomolgus Macaques closely resembles the various manifestations of human M-tuberculosis infection [J].
Capuano, SV ;
Croix, DA ;
Pawar, S ;
Zinovik, A ;
Myers, A ;
Lin, PL ;
Bissel, S ;
Fuhrman, C ;
Klein, E ;
Flynn, JL .
INFECTION AND IMMUNITY, 2003, 71 (10) :5831-5844
[9]   QUANTITATION OF THE PHENOLIC GLYCOLIPID OF MYCOBACTERIUM-LEPRAE AND RELEVANCE TO GLYCOLIPID ANTIGENEMIA IN LEPROSY [J].
CHO, SN ;
HUNTER, SW ;
GELBER, RH ;
REA, TH ;
BRENNAN, PJ .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (03) :560-569
[10]   Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death [J].
Clay, Hilary ;
Volkman, Hannah E. ;
Ramakrishnan, Lalita .
IMMUNITY, 2008, 29 (02) :283-294